SEC Company Response from ENvue Medical, Inc. (FEED) (CIK 0001326706) (FEED) — May 21, 2019
ENvue Medical, Inc. (FEED) (CIK 0001326706)
Date: May 21, 2019 · CIK: 0001326706 · Accession: 0001615774-19-008192
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229106
Letter
NanoVibronix, Inc.
525 Executive Blvd.
Elmsford, New York 10523
(914) 233-3004
May 21, 2019
Via EDGAR Correspondence
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.W.
Washington, D.C. 20549
Re: NanoVibronix, Inc.
Registration Statement on Form S-3
Initially Filed December 31, 2018
File No. 333-229106
Ladies and Gentlemen:
NanoVibronix, Inc. (the “Company”) is enclosing herewith an acceleration request with respect to the above captioned registration statement. In connection with such request, the Company hereby acknowledges that:
● should the Commission or the staff, acting pursuant to delegated authority, declare the registration statement effective, it does not foreclose the Commission from taking any action with respect to the registration statement;
● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the registration statement effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the registration statement; and
● the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
NanoVibronix, Inc.
By: /s/ Stephen Brown
Name: Stephen Brown
Title: Chief Financial Officer
cc: Brian Murphy, Chief Executive Officer, NanoVibronix, Inc.
Aurora Cassirer, Esq. Troutman Sanders, LLP
Joseph Walsh, Esq., Troutman Sanders, LLP
NanoVibronix, Inc.
525 Executive Blvd.
Elmsford, New York 10523
(914) 233-3004
May 21, 2019
Via EDGAR Correspondence
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.W.
Washington, D.C. 20549
Re: NanoVibronix, Inc.
Registration Statement on Form S-3
Initially Filed December 31, 2018
File No. 333-229106
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, the undersigned registrant under the above-referenced registration statement hereby requests acceleration of the effective date of the registration statement to May 23, 2019, at 4:00 p.m., New York time, or as soon as practicable thereafter. Please notify our outside counsel, Joseph Walsh, Esq., by phone at (212) 704-6030, by fax at (212) 704-5919, or by email at joseph.walsh@troutman.com of the date and time that the registration statement has been declared effective.
Very truly yours,
NanoVibronix, Inc.
Show Raw Text
CORRESP
1
filename1.htm
NanoVibronix,
Inc.
525 Executive Blvd.
Elmsford, New York 10523
(914) 233-3004
May 21, 2019
Via
EDGAR Correspondence
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.W.
Washington,
D.C. 20549
Re:
NanoVibronix, Inc.
Registration
Statement on Form S-3
Initially
Filed December 31, 2018
File
No. 333-229106
Ladies
and Gentlemen:
NanoVibronix,
Inc. (the “Company”) is enclosing herewith an acceleration request with respect to the above captioned registration
statement. In connection with such request, the Company hereby acknowledges that:
● should
the Commission or the staff, acting pursuant to delegated authority, declare the registration
statement effective, it does not foreclose the Commission from taking any action with
respect to the registration statement;
● the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring
the registration statement effective, does not relieve the Company from its full responsibility
for the adequacy and accuracy of the disclosure in the registration statement; and
● the
Company may not assert staff comments and the declaration of effectiveness as a defense
in any proceeding initiated by the Commission or any person under the federal securities
laws of the United States.
Very truly yours,
NanoVibronix, Inc.
By:
/s/ Stephen Brown
Name: Stephen Brown
Title: Chief Financial Officer
cc: Brian
Murphy, Chief Executive Officer, NanoVibronix, Inc.
Aurora
Cassirer, Esq. Troutman Sanders, LLP
Joseph
Walsh, Esq., Troutman Sanders, LLP
NanoVibronix,
Inc.
525 Executive Blvd.
Elmsford, New York 10523
(914) 233-3004
May 21, 2019
Via
EDGAR Correspondence
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.W.
Washington,
D.C. 20549
Re:
NanoVibronix, Inc.
Registration
Statement on Form S-3
Initially
Filed December 31, 2018
File
No. 333-229106
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the Securities Act of 1933, as amended, the undersigned registrant under the above-referenced registration statement
hereby requests acceleration of the effective date of the registration statement to May 23, 2019, at 4:00 p.m., New York time,
or as soon as practicable thereafter. Please notify our outside counsel, Joseph Walsh, Esq., by phone at (212) 704-6030, by fax
at (212) 704-5919, or by email at joseph.walsh@troutman.com of the date and time that the registration statement has been
declared effective.
Very truly yours,
NanoVibronix, Inc.
By:
/s/ Stephen Brown
Name: Stephen Brown
Title: Chief Financial Officer
cc: Brian
Murphy, Chief Executive Officer, NanoVibronix, Inc.
Aurora
Cassirer, Esq. Troutman Sanders, LLP
Joseph
Walsh, Esq., Troutman Sanders, LLP